While simplified, our in vitro system offers the advantage of isolating the direct effects of IL-27 on CLL cells, allowing a clearer assessment of cytokine-dependent modulation of TIM-3 and Gal-9 without interference from complex microenvironmental factors. Here, LGALS9 is linked to B-cell chronic lymphocytic leukemia.